Demonstrating Commercial Promise, UChicago Researcher Recognized for Novel Cancer Drug Delivery System

University of Chicago researcher and startup founder Xiaoyang Wu has received the 2022 Duckworth Family Commercial Promise Award for his work developing a novel cancer drug delivery system. The award…

Cancer’s Achilles’ Heel? UChicago Startup Secures $7 Million to Develop ‘Game-Changer’ Treatments

Onchilles Pharma recently closed its Series A funding round, bringing in approximately $7 million, including a $500,000 investment from the University of Chicago’s Startup Investment Fund. Cofounded by UChicago Associate…

Novel Wound Dressing Seals, Protects, and Prevents Scar Formation with ‘Significant’ Advantages

University of Chicago researcher Xiaoyang Wu has developed a novel wound dressing that can stop bleeding while preventing infection and scarring using a single material, which has potential applications in…

Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment

More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American…

Patent of the Week: Identifying High-Risk Triple Negative Breast Cancer Patients

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer and has the least favorable prognosis, as there are fewer targeted medicines available. Accounting for about…

Genetically Engineered Skin to Treat Disease, Promote Scarless Wound Healing, and More

The largest organ in the human body, skin is a robust system with great potential to support not only basic research, but to serve as a platform for stem cell…